JPH11515011A - アモキシリンの結晶塩の製造法 - Google Patents
アモキシリンの結晶塩の製造法Info
- Publication number
- JPH11515011A JPH11515011A JP9516301A JP51630197A JPH11515011A JP H11515011 A JPH11515011 A JP H11515011A JP 9516301 A JP9516301 A JP 9516301A JP 51630197 A JP51630197 A JP 51630197A JP H11515011 A JPH11515011 A JP H11515011A
- Authority
- JP
- Japan
- Prior art keywords
- amoxicillin
- ethanol
- salt
- sodium
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title claims abstract description 82
- 229960003022 amoxicillin Drugs 0.000 title claims abstract description 73
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title claims abstract description 73
- 150000003839 salts Chemical class 0.000 title claims abstract description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 142
- 239000002904 solvent Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 18
- 159000000000 sodium salts Chemical class 0.000 claims abstract description 17
- 238000002425 crystallisation Methods 0.000 claims abstract description 7
- 230000008025 crystallization Effects 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 46
- 150000001412 amines Chemical class 0.000 claims description 23
- -1 amine salt Chemical class 0.000 claims description 21
- 229960002793 amoxicillin sodium Drugs 0.000 claims description 21
- ILVPFTMKCHREDJ-UHFFFAOYSA-N methyl 5-amino-2-fluorobenzoate Chemical compound COC(=O)C1=CC(N)=CC=C1F ILVPFTMKCHREDJ-UHFFFAOYSA-N 0.000 claims description 21
- 150000001805 chlorine compounds Chemical class 0.000 claims description 17
- 229960004920 amoxicillin trihydrate Drugs 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 4
- 150000002894 organic compounds Chemical class 0.000 claims description 3
- 229940126062 Compound A Drugs 0.000 claims 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 26
- 238000009472 formulation Methods 0.000 description 19
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 15
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- 238000003556 assay Methods 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- BYHDFCISJXIVBV-YWUHCJSESA-M amoxicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=C(O)C=C1 BYHDFCISJXIVBV-YWUHCJSESA-M 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 5
- 102100040360 Angiomotin Human genes 0.000 description 5
- 102100032373 Coiled-coil domain-containing protein 85B Human genes 0.000 description 5
- 101000891154 Homo sapiens Angiomotin Proteins 0.000 description 5
- 101000868814 Homo sapiens Coiled-coil domain-containing protein 85B Proteins 0.000 description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 5
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 5
- 229940043279 diisopropylamine Drugs 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 125000005270 trialkylamine group Chemical group 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 4
- 239000012320 chlorinating reagent Substances 0.000 description 4
- 125000005265 dialkylamine group Chemical group 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 229910017053 inorganic salt Inorganic materials 0.000 description 3
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 150000004684 trihydrates Chemical class 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000013557 residual solvent Substances 0.000 description 2
- SJRDNQOIQZOVQD-UHFFFAOYSA-M sodium;2,2-dimethylpropanoate Chemical compound [Na+].CC(C)(C)C([O-])=O SJRDNQOIQZOVQD-UHFFFAOYSA-M 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229950010765 pivalate Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- VYPDUQYOLCLEGS-UHFFFAOYSA-M sodium;2-ethylhexanoate Chemical compound [Na+].CCCCC(CC)C([O-])=O VYPDUQYOLCLEGS-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.溶媒としてのエタノール中でのアモキシリンの結晶塩の製造法。 2.(i)アモキシリンをエタノールに溶解する工程、 (ii)塩化化合物の存在下でアモキシリンの塩を結晶化する工程 を特徴とする、アモキシリンの結晶塩の製造法。 3.(i)アモキシリンのアミン塩をエタノール中で製造する工程、 (ii)塩化化合物の存在下で該生成物を結晶化する工程 を特徴とする、アモキシリンの結晶塩の製造法。 4.工程(i)において、アモキシリンをアミンの混合物と反応させる、請求項 2または3に記載の方法。 5.アモキシリンの塩を、エタノール性溶液中でアモキシリンのアミン塩と塩化 化合物との混合物から結晶化させる、アモキシリンの結晶塩の製造法。 6.アモキシリンのナトリウム塩を製造する、請求項1〜5のいずれか一項に記 載の方法。 7.(i)アモキシリン三水和物をアミンの存在下でエタノールに溶解する工程 、 (ii)得られた溶液をエタノール中で有機化合物のナトリウム塩とさらに反応さ せる工程 を含む、アモキシリンナトリウムの製造法。 8.工程(i)においてアミンの混合物を使用する、請求項7に記載の方法。 9.アモキシリンの塩の結晶化における溶媒としてのエタノールの使用。 10.エタノールを含むアモキシリンの結晶塩。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9521921.8A GB9521921D0 (en) | 1995-10-26 | 1995-10-26 | Organic compounds |
GB9611088.7 | 1996-05-28 | ||
GB9521921.8 | 1996-05-28 | ||
GBGB9611088.7A GB9611088D0 (en) | 1996-05-28 | 1996-05-28 | Organic compounds |
PCT/EP1996/004682 WO1997015579A1 (en) | 1995-10-26 | 1996-10-28 | Production of a crystalline salt of amoxicillin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11515011A true JPH11515011A (ja) | 1999-12-21 |
JP4104166B2 JP4104166B2 (ja) | 2008-06-18 |
Family
ID=26308006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51630197A Expired - Lifetime JP4104166B2 (ja) | 1995-10-26 | 1996-10-28 | アモキシシリンの結晶塩の製造法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US6103897A (ja) |
EP (1) | EP0871632B1 (ja) |
JP (1) | JP4104166B2 (ja) |
AT (1) | ATE237621T1 (ja) |
AU (1) | AU7494496A (ja) |
DE (1) | DE69627533T2 (ja) |
DK (1) | DK0871632T3 (ja) |
ES (1) | ES2197253T3 (ja) |
PT (1) | PT871632E (ja) |
TW (1) | TW347383B (ja) |
WO (1) | WO1997015579A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1086109A4 (en) * | 1998-06-01 | 2001-12-19 | Smithkline Beecham Corp | PROCESS FOR THE PREPARATION OF CRYSTALLINE AMOXYCILLIN SALTS |
US6211384B1 (en) | 1999-08-30 | 2001-04-03 | Novartis Pharmaceuticals Corp. | Methods for the acylation of amine compounds |
AT412213B (de) | 2000-05-30 | 2004-11-25 | Sandoz Ag | Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte |
CN101633663B (zh) * | 2009-08-28 | 2011-12-21 | 沈阳顺旺动物药业有限公司 | 一种青霉素类钠、钾盐的合成方法 |
CN102838620B (zh) * | 2012-09-05 | 2014-07-30 | 河北科技大学 | 一种阿莫西林钠结晶的制备工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1286199A (en) * | 1970-03-16 | 1972-08-23 | Beecham Group Ltd | Penicillins |
US3932386A (en) * | 1973-06-18 | 1976-01-13 | American Home Products Corporation | Sodium 6-(L-aminocyclohexane carboxamido)penicillanic acid |
GB1464026A (en) * | 1974-09-25 | 1977-02-09 | Beecham Group Ltd | Preparation of beta-lactam antibiotics |
GB1463563A (en) * | 1974-10-10 | 1977-02-02 | Beecham Group Ltd | Pharmaceutical compositions |
DE3474023D1 (en) * | 1983-06-10 | 1988-10-20 | Beecham Group Plc | Crystalline amoxycillin salt |
DE3431273A1 (de) * | 1984-08-25 | 1986-03-06 | Bayer Ag, 5090 Leverkusen | Kristallines natriumsalz der d-6-((alpha)-(2-oxo-3-furfuryl-iden-amino-imidazolidin-1-yl)-carbonylamino)-thienyl-2-acetamido)-penicillansaeure, verfahren zur herstellung und seine verwendung in arzneimitteln |
ES8606871A1 (es) * | 1985-10-21 | 1986-06-01 | Antibioticos Sa | Un procedimiento de preparacion de amoxicilina sodica |
IT1255716B (it) * | 1992-10-05 | 1995-11-10 | Procedimento per la preparazione di antibiotici beta-lattamici sterili |
-
1996
- 1996-10-23 TW TW085112977A patent/TW347383B/zh not_active IP Right Cessation
- 1996-10-28 DK DK96937268T patent/DK0871632T3/da active
- 1996-10-28 US US09/066,476 patent/US6103897A/en not_active Expired - Lifetime
- 1996-10-28 JP JP51630197A patent/JP4104166B2/ja not_active Expired - Lifetime
- 1996-10-28 DE DE69627533T patent/DE69627533T2/de not_active Expired - Lifetime
- 1996-10-28 WO PCT/EP1996/004682 patent/WO1997015579A1/en active IP Right Grant
- 1996-10-28 AU AU74944/96A patent/AU7494496A/en not_active Abandoned
- 1996-10-28 ES ES96937268T patent/ES2197253T3/es not_active Expired - Lifetime
- 1996-10-28 AT AT96937268T patent/ATE237621T1/de active
- 1996-10-28 PT PT96937268T patent/PT871632E/pt unknown
- 1996-10-28 EP EP96937268A patent/EP0871632B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1997015579A1 (en) | 1997-05-01 |
ES2197253T3 (es) | 2004-01-01 |
TW347383B (en) | 1998-12-11 |
US6103897A (en) | 2000-08-15 |
PT871632E (pt) | 2003-08-29 |
DE69627533T2 (de) | 2003-12-18 |
DE69627533D1 (de) | 2003-05-22 |
AU7494496A (en) | 1997-05-15 |
ATE237621T1 (de) | 2003-05-15 |
JP4104166B2 (ja) | 2008-06-18 |
DK0871632T3 (da) | 2003-07-28 |
EP0871632A1 (en) | 1998-10-21 |
EP0871632B1 (en) | 2003-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4912211A (en) | Method for producing pure crystalline antibiotic products | |
JPH0641143A (ja) | クラブラン酸塩の製造方法 | |
JPH11515011A (ja) | アモキシリンの結晶塩の製造法 | |
JPH10511377A (ja) | セフォタキシムの製造 | |
US5210288A (en) | Process for the preparation of d-(-)-4-hydroxyphenylglycine and l-(+)-4-hydroxyphenylglycine, starting from d.l.-4-hydroxyphenylglycine | |
KR970010068B1 (ko) | 무균적인 β-락탐계 항생제의 제조방법 | |
JPH11501023A (ja) | クラブラン酸塩 | |
KR100687167B1 (ko) | α-(2-4-디술포페닐)-N-tert-부틸니트론 및 제약상허용되는 그의 염의 신규 제조 방법 | |
US4219641A (en) | Process for preparing erythromycin succinate | |
JP2002517398A (ja) | アモキシシリンの結晶性塩の製造方法 | |
JPH034555B2 (ja) | ||
EP1281713B1 (en) | Process for the preparation of the sodium salt of 6[D-(-)alpha-4-(ethyl-2,3-dioxo-1-piperazinocarbonyl-amino)phenylacetamido]penicillanic acid | |
JPH03240793A (ja) | アンフォテリシンbの精製方法および組成物 | |
JP2001526291A (ja) | アンピシリンプロドラッグエステルの溶液の精製方法 | |
MXPA02005330A (es) | Procedimiento para la preparacion de hidrocloruro de epinastina en la modificacion cristalina de alto punto de fusion. | |
US20020137926A1 (en) | Process for preparing crystalline salts of amoxycillin | |
EP0341991A2 (en) | Method for recovery of antibiotics from mother liquors and novel pharmaceutically-acceptable salts thereof | |
KR0169534B1 (ko) | 고밀도의 고결정성 세포페라존 나트륨염 및 그의 제조방법 | |
JP3523661B2 (ja) | 2−アルキル−4−ハロゲノ−5−ホルミルイミダゾールの精製方法 | |
KR820001179B1 (ko) | 6-메톡시-α-메틸-2-나프탈렌초산 라세미체를 그의 대장체로 분할하는 방법. | |
CN117447488A (zh) | 一种氨苄西林钠的制备方法 | |
KR100512870B1 (ko) | 7α-메톡시세팔로스포린 유도체 나트륨염 7수화물의제조방법 | |
HU194893B (en) | Process for producing cristalline sodium salt of d-6-brace alpha-(/2-oxo-3-furfuriliden-amino-imidazolidin-1-yl/-carbonyl-amino)-thienyl-2-acetamido-brace closed-penicillanic acid and pharmaceutical compositions containing them | |
CN115353524A (zh) | 一种头孢呋辛钠的合成方法 | |
KR20000013423A (ko) | 무정형 세푸록심 악세틸의 합성방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041124 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20041124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070724 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071017 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071126 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080123 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080311 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080325 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4104166 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110404 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110404 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110404 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120404 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130404 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130404 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140404 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |